Vijay Mohan | Cancer Drug Discovery | Innovative Research Award

Published-on by Indian Scientist

Innovative Research Award

Vijay Mohan
Galgotias University

Vijay Mohan
Affiliation Galgotias University
Country India
Scopus ID 57472028500
Documents 2
Citations 23
h-index 2
Subject Area Cancer Drug Discovery
Event Indian Scientist Awards

Vijay Mohan is associated with Galgotias University, India, and is engaged in research related to Cancer Drug Discovery. His academic work focuses on scientific approaches that contribute to understanding therapeutic targets, drug development strategies, and translational biomedical research. Through scholarly publications and research dissemination, he has contributed to the growing body of knowledge supporting advancements in oncology and pharmaceutical sciences.[1]

Abstract

The Innovative Research Award recognizes researchers who demonstrate originality, scientific rigor, and meaningful scholarly contributions. Vijay Mohan’s research profile reflects engagement in Cancer Drug Discovery, a field that integrates biomedical science, medicinal chemistry, pharmacology, and computational approaches to identify and develop effective therapeutic interventions. His publication and citation record illustrates active participation in scientific inquiry and knowledge dissemination within the biomedical research community.[1][2]

Keywords

Cancer Drug Discovery; Oncology Research; Therapeutic Development; Pharmaceutical Sciences; Biomedical Innovation; Precision Medicine; Drug Design; Translational Research; Cancer Therapeutics; Innovative Research.

Introduction

Cancer remains one of the most significant global health challenges, creating an ongoing need for innovative therapeutic strategies and improved treatment approaches. Cancer Drug Discovery encompasses multidisciplinary efforts directed toward identifying novel compounds, therapeutic targets, and personalized treatment methodologies. Researchers working in this field contribute to advancements that support both fundamental scientific understanding and practical clinical applications.[2]

Research Profile

Vijay Mohan is affiliated with Galgotias University and has established a documented research presence within Cancer Drug Discovery. According to available scholarly indicators, his profile includes two indexed publications, twenty-three citations, and an h-index of two. These metrics reflect research visibility and participation in academic discourse within biomedical and pharmaceutical research domains.[1]

  • Research focus on cancer therapeutics and drug discovery.
  • Interest in translational and biomedical research methodologies.
  • Contribution to scientific publication and scholarly communication.
  • Participation in interdisciplinary healthcare research initiatives.

Research Contributions

Research contributions within Cancer Drug Discovery support the identification of novel therapeutic compounds and improve understanding of disease mechanisms. Scientific efforts in this area often involve target validation, medicinal chemistry, molecular biology, and pharmacological evaluation. Such contributions assist in the development of more effective and personalized treatment strategies for cancer patients.[2]

  • Investigation of therapeutic targets relevant to oncology.
  • Support for innovative approaches to drug development.
  • Contribution to evidence-based biomedical research.
  • Participation in scientific initiatives focused on healthcare advancement.

Publications

The publication record associated with Vijay Mohan reflects scholarly engagement within biomedical and pharmaceutical research. Publications serve as an important mechanism for communicating scientific findings, facilitating peer review, and supporting future investigations in cancer-related research fields.[1]

  1. Research publications related to cancer therapeutics.
  2. Scientific articles supporting drug discovery initiatives.
  3. Peer-reviewed contributions to biomedical literature.
  4. Collaborative research outputs within healthcare sciences.

Research Impact

Research impact may be evaluated through scholarly publications, citations, academic visibility, and contribution to scientific advancement. The citation record associated with Vijay Mohan indicates engagement with the research community and demonstrates that his work has contributed to ongoing scientific discussions within cancer-related biomedical research.[1]

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate originality, scientific relevance, and meaningful academic contribution. Based on available research indicators and documented scientific engagement, Vijay Mohan exhibits characteristics aligned with innovative research practice through his involvement in Cancer Drug Discovery and biomedical research initiatives. These attributes support consideration within research recognition and excellence programs.[1]

Conclusion

Vijay Mohan’s research profile reflects continued engagement in Cancer Drug Discovery and biomedical research. Through scholarly publication, scientific communication, and contributions to oncology-related investigations, he participates in efforts aimed at advancing therapeutic innovation and healthcare outcomes. The Innovative Research Award provides an appropriate framework for recognizing such scholarly contributions and encouraging continued research excellence.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Vijay Mohan, Author ID 57472028500. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57472028500
  2. Role of Transcription Factor BEND3 and Its Potential Effect on Cancer Progression
    https://www.mdpi.com/2072-6694/15/14/3685

Harpreet Singh | Molecular Biology | Innovative Research Award

Published-on by Indian Scientist

Innovative Research Award

Harpreet Singh
Affiliation GD Goenka University
Country India
Scopus ID 59940947700
Documents 1
Subject Area Molecular Biology
Event Indian Scientist Awards
ORCID 0009-0003-3856-571X

Harpreet Singh

GD Goenka University

Harpreet Singh, affiliated with GD Goenka University, India. The profile highlights contributions within the field of Molecular Biology, emphasizing scholarly output, citation influence, research relevance, and academic engagement. The assessment is structured in a neutral and evidence-oriented manner consistent with academic recognition frameworks such as the Indian Scientist Awards.[1]

Abstract

This article provides a structured academic overview of Harpreet Singh’s research profile within Molecular Biology. The assessment considers scholarly influence, citation performance, scientific relevance, and contributions to biological research. Molecular Biology remains a critical discipline underpinning advances in genetics, biotechnology, biomedical sciences, and molecular diagnostics. The researcher’s citation record reflects measurable engagement with the scientific community and demonstrates the dissemination of knowledge through recognized scholarly channels.[1][2]

Keywords

Molecular Biology, Biotechnology, Scientific Research, Genomics, Research Excellence, Citation Analysis, Biological Sciences, Academic Recognition, Innovation in Science, Indian Scientist Awards.

Introduction

Molecular Biology is a foundational scientific discipline that investigates the molecular mechanisms underlying cellular function, genetic regulation, and biological processes. Research in this field contributes to advances in medicine, agriculture, environmental sciences, biotechnology, and pharmaceutical development. Continuous discoveries within molecular biology drive innovation and expand understanding of life at the molecular level.[3]

Researchers in this domain contribute through experimental investigation, theoretical development, and interdisciplinary collaboration. Their work supports the translation of scientific findings into practical applications that benefit society and improve scientific knowledge systems.[4]

Research Profile

Harpreet Singh is affiliated with GD Goenka University and is associated with scholarly activities within the field of Molecular Biology. Available bibliometric information demonstrates citation influence and research visibility through recognized academic indexing systems. The profile reflects participation in scientific communication and contribution to ongoing developments in biological sciences.[1]

  • Scopus Author ID: 59940947700
  • Institution: GD Goenka University
  • Country: India
  • Total Citations: 387
  • Primary Subject Area: Molecular Biology
  • Recognition Event: Indian Scientist Awards

Research Contributions

The researcher’s scholarly activities contribute to the advancement of molecular and biological sciences through participation in research, publication, and scientific knowledge dissemination. Molecular Biology research frequently intersects with biotechnology, genetics, cellular biology, and biomedical innovation, thereby creating opportunities for interdisciplinary impact and scientific advancement.[2]

  • Contribution to molecular and cellular biology research initiatives.
  • Participation in scientific investigations addressing biological mechanisms.
  • Support for interdisciplinary studies involving biotechnology and life sciences.
  • Publication and dissemination of research findings through scholarly channels.
  • Engagement with emerging scientific developments relevant to molecular biology.

Publications

Scientific publications serve as a primary mechanism for communicating research findings and supporting knowledge development within the global scientific community. The available citation record associated with this profile indicates that the researcher’s scholarly outputs have been referenced by other investigators, contributing to academic discourse and ongoing scientific inquiry.[1]

  1. Peer-reviewed research publications in biological and molecular sciences.
  2. Scholarly contributions supporting advances in biotechnology and life sciences.
  3. Research outputs disseminated through recognized academic platforms.
  4. Scientific publications contributing to citation-based scholarly influence.

Research Impact

Research impact may be evaluated through scholarly visibility, citation influence, knowledge dissemination, and contribution to scientific advancement. The documented citation count of 387 indicates meaningful engagement with the scientific community and suggests that published research has contributed to ongoing academic discussions within relevant scientific disciplines.[1]

Beyond bibliometric measures, the broader value of molecular biology research lies in its potential applications in healthcare, biotechnology, agriculture, environmental sustainability, and translational science. Such contributions strengthen the relevance of scholarly research within both academic and societal contexts.[3][4]

Award Suitability

The Innovative Research Award recognizes scholarly achievement, scientific contribution, and the advancement of knowledge through impactful research. Based on available bibliometric evidence and demonstrated engagement within Molecular Biology, Harpreet Singh exhibits characteristics consistent with the objectives of academic recognition programs that emphasize innovation, research quality, and scientific influence.[1]

The combination of scholarly visibility, citation performance, and contribution to biological sciences supports consideration for recognition within the Indian Scientist Awards framework. Continued research productivity and scientific engagement are expected to further strengthen the academic significance of the researcher’s work.[2][4]

Conclusion

Harpreet Singh’s academic profile reflects meaningful engagement in Molecular Biology research and measurable scholarly influence through citation performance and scientific dissemination. The available evidence highlights participation in knowledge creation and contribution to ongoing developments within biological sciences. These characteristics align with the objectives of the Innovative Research Award and support recognition of scholarly excellence within the Indian Scientist Awards program.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Harpreet Singh, Author ID 59940947700. Scopus. https://www.scopus.com/authid/detail.uri?authorId=59940947700
  2. CRISPR: Revolutionizing genetic science and ethics
    https://www.sciencedirect.com/science/article/abs/pii/S3050475926003659?via%3Dihub
  3. Therapeutic Potential of Plumbagin: Redox Modulation and Pathway Inhibition in Cancer and Neuroinflammation
    https://jetir.org/view.php?paper=JETIR2508509
  4. Green-synthesized biogenic nanoflowers as targeted delivery platforms to combat drug-resistant tuberculosis in India
    https://www.sciencedirect.com/science/article/abs/pii/S0019570726001253?via%3Dihub

Jon Jyoti Sahariah | Medicinal Chemistry | Research Excellence Award

Published-on by Indian Scientist

Research Excellence Award

Jon Jyoti Sahariah
Dibrugarh University, India

Jon Jyoti Sahariah
Affiliation Dibrugarh University
Country India
Scopus ID 57225212218
Documents 19
Citations 125
h-index 6
Subject Area Medicinal Chemistry
Event Indian Scientist Awards

Jon Jyoti Sahariah is an academic researcher affiliated with Dibrugarh University, India, whose scholarly activities are associated with medicinal chemistry, pharmaceutical sciences, drug delivery systems, and therapeutic development. His published research contributions demonstrate engagement with contemporary challenges in drug discovery, targeted therapeutics, and biomedical innovation. Through peer-reviewed publications, citation impact, and interdisciplinary collaborations, he has contributed to advancing scientific understanding within medicinal chemistry and related biomedical disciplines.[1]

Abstract

This article presents an academic overview of Jon Jyoti Sahariah and his scholarly contributions within medicinal chemistry and pharmaceutical research. The profile summarizes research interests, publication records, citation metrics, scientific influence, and relevance to recognition through the Research Excellence Award. The assessment is based on publicly available scholarly indicators and peer-reviewed academic outputs.[1]

Keywords

Medicinal Chemistry, Drug Discovery, Pharmaceutical Sciences, Targeted Drug Delivery, Cancer Therapeutics, Liposomal Formulations, Biomedical Research, Therapeutic Development, Scientific Publications, Research Excellence.

Introduction

Medicinal chemistry plays a critical role in the development of novel therapeutic agents and advanced healthcare solutions. Researchers working in this field contribute to the identification, optimization, and evaluation of biologically active compounds for the prevention and treatment of diseases. Jon Jyoti Sahariah’s academic activities align with these objectives through investigations focused on pharmaceutical formulations, drug delivery systems, and therapeutic innovations. His work reflects interdisciplinary collaboration across chemistry, pharmacy, and biomedical sciences.[2]

Research Profile

The scholarly profile of Jon Jyoti Sahariah demonstrates sustained participation in scientific research and publication. According to available bibliometric indicators, his research output includes nineteen indexed documents, 125 citations, and an h-index of six. These metrics indicate measurable academic visibility and engagement within the scientific community. His publications encompass medicinal chemistry, drug delivery technologies, cancer therapeutics, and pharmaceutical innovations.[1]

  • Affiliation with Dibrugarh University, India.
  • Research specialization in medicinal chemistry and pharmaceutical sciences.
  • Indexed publications in peer-reviewed journals.
  • Interdisciplinary collaboration involving drug discovery and therapeutic development.

Research Contributions

Jon Jyoti Sahariah has contributed to studies involving natural bioactive compounds, targeted cancer therapies, liposomal drug delivery systems, and pharmaceutical technologies. Several publications examine mechanisms for improving therapeutic efficacy while reducing adverse effects associated with conventional treatments. Research efforts in these domains contribute to ongoing developments in precision medicine and translational pharmaceutical science.[3]

  • Investigation of natural compounds with therapeutic potential.
  • Research on advanced liposomal drug delivery systems.
  • Contributions to targeted cancer therapy methodologies.
  • Participation in multidisciplinary biomedical research projects.

Publications

Selected scholarly works associated with Jon Jyoti Sahariah include publications addressing cancer chemotherapy, liposomal drug delivery, and medicinal chemistry innovations. Representative studies include highly cited articles focusing on natural bioactive compounds and targeted therapeutic approaches.[3]

  1. Cancer Chemotherapy via Natural Bioactive Compounds.
  2. Advancing Liposomal Doxorubicin for Targeted Cancer Therapy.
  3. Research involving pharmaceutical formulation and drug delivery technologies.
  4. Studies related to medicinal chemistry and therapeutic development.

Research Impact

Research impact can be assessed through publication output, citation frequency, collaborative scholarship, and relevance to scientific advancement. The citation record associated with Jon Jyoti Sahariah indicates that his work has been referenced by researchers in related fields, reflecting scholarly engagement and knowledge dissemination. Contributions to pharmaceutical sciences and medicinal chemistry support ongoing scientific dialogue regarding improved therapeutic interventions.[1]

Award Suitability

The Research Excellence Award recognizes researchers demonstrating meaningful scholarly contributions, scientific productivity, and academic influence. Based on available publication records, citation metrics, and participation in medicinal chemistry research, Jon Jyoti Sahariah exhibits characteristics consistent with the objectives of academic recognition programs. His work contributes to knowledge advancement in pharmaceutical and biomedical sciences while supporting innovation in therapeutic research.[1][4]

Conclusion

Jon Jyoti Sahariah has established a scholarly profile characterized by contributions to medicinal chemistry, drug delivery systems, and pharmaceutical sciences. Through peer-reviewed publications, citation impact, and collaborative scientific efforts, he has participated in research addressing significant healthcare and therapeutic challenges. His academic record supports consideration for professional recognition through the Research Excellence Award and reflects ongoing engagement with scientific advancement.[1]

References

  1. Scopus author details: Jon Jyoti Sahariah, Author ID 57225212218. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57225212218
  2. Cancer chemotherapy via natural bioactive compounds. https://www.benthamdirect.com/content/journals/cddt/10.2174/1570163819666220331095744
  3. From bench to bedside: Advancing liposomal doxorubicin for targeted cancer therapy. https://www.sciencedirect.com/science/article/pii/S2666845925000601
  4. Revolutionizing patient care: 3D printing for customized medical devices and therapeutics. https://link.springer.com/article/10.1007/s44174-025-00324-2

Rekha Bansal | Medicine and Dentistry | Research Excellence Award

Published-on by Indian Scientist

Prof. Dr. Rekha Bansal | Medicine and Dentistry | Research Excellence Award

Shri Lal Bahadur Shastri Government Medical College, India

Prof. Dr. Rekha Bansal is a distinguished academician and clinician in pulmonary medicine, currently serving as Professor and Head of Department. She holds advanced qualifications in respiratory diseases and specialized training in thoracic oncology and palliative care. With extensive experience across leading medical institutions, she has contributed significantly to teaching, clinical practice, and research. Her interests include tuberculosis, lung cancer, and antimicrobial studies. Recognized for her scholarly publications and academic leadership, she continues to advance respiratory healthcare and medical education.

Citation Metrics (Google Scholar)

150
100
50
10
0

Citations
134

h-index
6

i10index
5

Citations

h-index

i10-index

Featured Publications

Mutthuraj Dasegowda | Cancer Biology, Oncology | Young Scientist Award

Published-on by Indian Scientist

Mr. Mutthuraj Dasegowda | Cancer Biology, Oncology | Young Scientist Award

JSS Academy of Higher Education and Research, India

Mr. Mutthuraj Dasegowda is a dedicated researcher in cancer biology and molecular sciences, currently pursuing doctoral studies focused on epigenetics and plant-based anticancer therapeutics. With a strong academic background in molecular biology, he has contributed to multidisciplinary research involving bioactive compounds and disease mechanisms. His experience includes research, teaching, and editorial roles, alongside active scientific collaborations. Recognized with academic awards and a research fellowship, his interests span natural products, cancer therapy, and immunology, reflecting a commitment to advancing innovative biomedical research.

Citation Metrics (Scopus)

10
8
6
4
0

Citations
2

Documents
6

h-index
1

Citations

Documents

h-index

Featured Publications

Gnana Ruba Priya Muthaiya | Medicinal Chemistry | Best Researcher Award

Published-on by Indian Scientist

Dr. Gnana Ruba Priya Muthaiya | Medicinal Chemistry | Best Researcher Award

Dayananda Sagar University, India

Dr. Gnana Ruba Priya Muthaiya is an accomplished pharmaceutical chemist and academician with advanced expertise in medicinal chemistry and drug design. Holding doctoral and postgraduate qualifications in pharmaceutical sciences, she has extensive experience in teaching, research, and mentoring across pharmacy disciplines. Her research focuses on computer-aided drug discovery, green synthesis, and anticancer therapeutics. With numerous peer-reviewed publications, patents, and scientific contributions, she has earned recognition for research excellence. Her work reflects a strong commitment to innovative drug development and impactful advancements in healthcare science.

Citation Metrics (Scopus)

70
50
30
10
0

Citations
60

Documents
1

h-index
1

Citations

Documents

h-index

Featured Publications


Artificial intelligence in screening: Models versus experiments


– Drug Discovery Today (Cited by 93 · Year: 2022)

Pooja Mathur | Pharmaceutics | Excellence in Research Award

Published-on by Indian Scientist

Pooja Mathur | Pharmaceutics | Excellence in Research Award

GD Goenka University | India

Dr. Pooja Mathur is an accomplished academic and researcher in Pharmaceutics with advanced doctoral training and extensive experience in teaching, research, and academic coordination. She has contributed significantly to pharmaceutical sciences through high-impact publications, books, patents, and interdisciplinary research. Her research interests include nanoformulations, drug delivery systems, phytopharmaceuticals, oncology therapeutics, and translational nanomedicine. She actively serves as a reviewer for reputed international journals and has received multiple recognitions for academic excellence, research output, and institutional contributions, reflecting her strong commitment to innovation and scholarly leadership.

Citation Metrics (Scopus)

150
20
10
5
0

Citations
149

Documents
22

h-index
4

Citations

Documents

h-index

Featured Publications

Subham Preetam | Nano-robots | Editorial Board Member

Published-on by Indian Scientist

Mr. Subham Preetam | Nano-robots | Editorial Board Member

Monash University | India

Mr. Subham Preetam is a distinguished Transfusion Medicine specialist recognized for impactful clinical research, academic contributions, and leadership in advancing evidence-based transfusion practices. With an h-index of 17, a research portfolio of 40 documents, and 1,102 citations across 904 citing documents, Mr. Preetam has established a strong scientific footprint in areas such as apheresis, patient blood management, therapeutic plasma exchange, leukocytapheresis, immunohematology, and transfusion safety. His academic journey includes an MBBS, an MD in Transfusion Medicine, and advanced clinical training through a PDCC in Apheresis and Blood Component Therapy. Professionally, he has served as Senior Resident and faculty in leading national medical institutes, contributing significantly to service development, SOP formulation, staff training, and quality systems in transfusion services. His research interests span clinical apheresis, hemovigilance, transfusion reactions, donor health, PBM strategies, and improving transfusion outcomes. Mr. Preetam has earned recognition through prestigious national awards and has contributed to international working groups, editorial activities, invited sessions, and collaborative projects that strengthen global transfusion medicine practices. His continued dedication reflects a commitment to improving clinical standards, fostering academic excellence, and promoting innovation in transfusion medicine for enhanced patient care.

Profiles: Scopus | Orcid

Featured Publications

Preetam, S., Lata, S., Aditi, Bora, J., Thapliyal, S., Mehta, S., Ramniwas, S., Deshwal, R., Rustagi, S., Talukdar, N., et al. (2025). Exosome-driven biohybrid nanorobots: Bridging nature and nanotechnology in biomedical innovation. RSC Advances. https://doi.org/10.1039/D5RA05296C

Dhasmana, A., Santhanam, A., Dhasmana, K., Malik, S., & Preetam, S. (2025). Innovative smart biosensors for cancer theranostics: A new frontier in detection, diagnosis, and beyond. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.100911

Dhasmana, A., Dobhal, P., Sati, A., Santhanam, A., Preetam, S., Malik, S., Joshi, N., Rustagi, S., & Deshwal, R. K. (2025). Synthesis of fungal polysaccharide-based nanoemulsions for cancer treatment. RSC Advances. https://doi.org/10.1039/D5RA01349F

Bhattacharya, T., Das, T., Preetam, S., & Chopra, H. (2025). Cutting-edge developments in agro-waste derived carbon nanomaterials and their multifaceted applications in agriculture: Enhancing crop imaging, nutrient efficiency, and plant health. Zeitschrift für Naturforschung C. https://doi.org/10.1515/znc-2024-0205

Preetam, S., Mishra, R., Thapliyal, S., Rustagi, S., Deshwal, R. K., Ramniwas, S., Dhasmana, A., Rajab, B. S., Alghamdi, S., & Malik, S. (2025). Bioactive coatings for cardiovascular stents: Modulating immune response for enhanced performance. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c01166

Rishabh Chalotra | Metabolic Disorders | Young Researcher Award

Published-on by Indian Scientist

Mr. Rishabh Chalotra | Metabolic Disorders | Young Researcher Award

Central University of Punjab | India

Rishabh Chalotra is a CSIR-Senior Research Fellow and doctoral scholar at the Laboratory of Neuroendocrinology and Metabolic Disorders, Department of Pharmacology, Central University of Punjab. His research focuses on addressing the complexities of Metabolic Syndrome through preclinical studies, exploring the therapeutic potential of natural phytoconstituents, and developing herbal-based solutions for improved clinical outcomes. He holds a Master’s degree in Pharmacology and a Bachelor’s degree in Pharmacy, with extensive experience in animal models, biochemical assays, pharmacokinetic studies, ELISA, RT-PCR, flow cytometry, and other advanced laboratory techniques. Rishabh has contributed to 18 peer-reviewed articles, six book chapters, and four patents, with his work cited 127 times, reflecting an h-index of 6 and an i10-index of 5. His publications explore metabolic disorders, diabetic complications, neurodegenerative diseases, and drug discovery, highlighting the role of flavonoids and natural compounds in therapeutic interventions. He has received the Young Investigator Award from the Indian Pharmacological Society and is a lifetime member of professional societies including the Indian Pharmacological Society, American Society for Microbiology, and British Pharmacological Society. His research combines experimental pharmacology with translational applications to bridge knowledge gaps and improve patient outcomes, positioning him as a promising contributor to global pharmacological research.

Profile: Google Scholar

Featured Publication

Chauhan, S., Chalotra, R., Rathi, A., Saini, M., Deol, S., Lard, M., & Gupta, S. (2023). Current approaches in healing of wounds in diabetes and diabetic foot ulcers. Current Bioactive Compounds, 19(3), 104–121.

Chalotra, R., Gupta, T., Chib, S., Amanat, M., Kumar, P., & Singh, R. (2024). Treatment of diabetic complications: Do flavonoids hold the keys? Critical Reviews in Food Science and Nutrition, 64(30), 11091–11112.

Maqbool, M., Chaudhary, K., Chalotra, R., Chauhan, S., & Dahiya, R. S. (2024). Phyto-pharmacology of most common Indian culinary spices and their potential in developing new pharmaceutical therapies. Current Traditional Medicine, 10(2), 117–140.

Sharma, K., Chib, S., Gupta, A., Singh, R., & Chalotra, R. (2024). Interplay between α-synuclein and parkin genes: Insights of Parkinson’s disease. Molecular Biology Reports, 51(1), 586.

Chib, S., Dutta, B. J., Chalotra, R., Abubakar, M., Kumar, P., Singh, T. G., & Singh, R. (2025). Role of flavonoids in mitigating the pathological complexities and treatment hurdles in Alzheimer’s disease. Phytotherapy Research, 39(2), 747–775.

Anupam Kanti Bag | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Dr. Anupam Kanti Bag | Pharmacology | Best Researcher Award

Dr. B.C. Roy College of Pharmacy and Allied Health Sciences |India

Dr. Anupam Kanti Bag is an accomplished pharmacology professional with strong academic and research credentials, reflected through 142 citations, an h-index of 3, and 3 i10-index publications, demonstrating consistent scholarly impact. His expertise spans microscopy, molecular biology, behavioral analysis, molecular docking, and network pharmacology, supported by extensive laboratory experience and a solid background in pharmaceutical sciences. He has significantly contributed to innovation through multiple national and international patents in drug formulation, medical device design, and pharmacokinetic enhancement, along with authoring books and contributing chapters in emerging areas of neurodegenerative disease research. His funded research work includes projects focusing on phytochemical formulations and nano-based therapeutic applications. Dr. Bag has served in various academic, administrative, and accreditation roles, including NAAC/NBA coordination, placement operations, exam cell management, and institutional leadership responsibilities across reputed pharmacy colleges. His technical skills extend to tools such as Pyrex, Pymol, Chimera, and Biovia Studio, combined with proficiency in cell culture handling, gene assays, ADR reporting, and laboratory instrumentation. Recognized with awards for academic excellence, mentoring, and scientific presentations, he continues to contribute to the advancement of pharmacology research with dedication to innovation, collaboration, and student development.

Profile: Google Scholar

Featured Publications

Bag, A. K., & Mumtaz, S. M. F. (2013). Hepatoprotective and nephroprotective activity of hydroalcoholic extract of Ipomoea staphylina leaves. Bangladesh Journal of Pharmacology, 8(3), 263–268.

Subramaniyan, V., Shaik, S., Bag, A., Manavalan, G., & Chandiran, S. (2018). Potential action of Rumex vesicarius (L.) against potassium dichromate and gentamicin-induced nephrotoxicity in experimental rats. Pakistan Journal of Pharmaceutical Sciences, 31(2), 509–516.

Mumtaz, S. M. F., Paul, S., & Bag, A. K. (2013). Effect of Sechium edule on chemical-induced kidney damage in experimental animals. Bangladesh Journal of Pharmacology, 8(1), 28–35.

Bag, A. K., & Hiremath, S. R. R. (2023). Neuropathic pain and its management. Indian Journal of Pharmacy Practice, 16(3).

Verma, P., Munirangappa, H., Bag, A. K., & Purushottam, H. (2023). Amelioration of hyperglycemia by hydroalcoholic extract of leaves of Ecbolium viride against experimental type II model in rats.